Funding for Go with Tourism a goner as pre-election spending cuts bite
A jobs platform that helped to develop the tourism and hospitality workforce had its government funding cut before the election after finding work for...
Source: nzherald.co.nz
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/YQDB3QQVTRAU7FVJSNNITTBA5Q.jpg)
Heather Kirkham News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Heather Kirkham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Heather Kirkham Today - Breaking & Trending Today
Tourism industry hopes minister will offer some solutions to industry challenges
The tourism industry is hopeful Tourism Minister Stuart Nash will offer some solutions to the challenges facing their sector.
Source: rnz.co.nz
#ACTRIMS2021 – Taking MS Medication in Pregnancy Lowers Care Costs
Click here to subscribe to the Multiple Sclerosis News Today Newsletter! 4.5 (2) Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Women with multiple sclerosis (MS) who continue taking disease-modifying therapies (DMTs) throughout pregnancy accrue lower non-maternity healthcare costs related to hospitalization, new research shows. Overall, the adjusted medical costs for patients who were consistently taking...
Source: multiplesclerosisnewstoday.com
Study tracks adherence to MS therapies in pregnant women, impact on hospitalizations
Senior Editor Women with MS who continue their disease-modifying therapy, or DMT, throughout pregnancy have lower hospitalization costs and use, compared to those who discontinued their therapy. That finding comes from a retrospective study conducted by Walgreens in collaboration with AllianceRx Walgreens Prime to understand how non-adherence to these women’s DMTs would impact healthcare cost and utilization over a two-year period. The researchers presented the findings on Feb. 26 at the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021. M...
Source: drugstorenews.com
Study demonstrates adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events
Share this article Share this article ORLANDO, Fla., March 1, 2021 /PRNewswire/ -- AllianceRx Walgreens Prime recently announced results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost. Researchers wanted to understand how non-adherence to their DMTs would impact healthcare cost and utilization over a two-year period. The findings suggest for those women continuing their therapy throughout pregnancy, hospitalization costs and use were lower, com...
Source: prnewswire.com